Brain receptor acts as switch for OCD symptoms in mice
A single chemical receptor in the brain is responsible for a range of symptoms in mice that are reminiscent of obsessive-compulsive disorder (OCD), according to a Duke University study that appears online in the journal Biological Psychiatry.
The findings provide a new mechanistic understanding of OCD and other psychiatric disorders and suggest that they are highly amenable to treatment using a class of drugs that has already been investigated in clinical trials.
“These new findings are enormously hopeful for considering how to approach neurodevelopmental diseases and behavioral and thought disorders,” said the study’s senior investigator Nicole Calakos, M.D., Ph.D., an associate professor of neurology and neurobiology at the Duke University Medical Center.
OCD, which affects 3.3 million people in the United States, is an anxiety disorder that is characterized by intrusive, obsessivethoughts and repeated compulsive behaviors that collectively interfere with a person’s ability to function in daily life.
In 2007, Duke researchers (led by Guoping Feng, who is now at the Massachusetts Institute of Technology) created a new mouse model of OCD by deleting a gene that codes for Sapap3, a protein that helps organize the connections between neurons so that the cells can communicate.
Similar to the way some people with OCD wash their hands excessively, the Sapap3-lacking mouse grooms itself excessively and shows signs of anxiety. Although researchers praised the new model for its remarkable similarity to a human psychiatric disorder, and have begun using it to study OCD, questions remain about how the loss of the Sapap3 gene leads to the grooming behaviors.
In the new study, Calakos’s team found that overactivity of a single type of receptor for neurotransmitters — mGluR5, found in a brain region involved in compulsive behaviors — was the major driver for the abnormal behaviors. When researchers gave Sapap3-lacking mice a chemical that blocks mGluR5, the grooming and anxiety behaviors abated.
“The reversibility of the symptoms was immediate — on a minute time frame,” Calakos said. In contrast, the original study describing Sapap3-lacking mice found that antidepressants could help treat symptoms but on the time scale of weeks, as is typical with these drugs in patients.
The immediate effects seen in the new study were also surprising, given that the brains of these mice appear developmentally immature and neurodevelopmental diseases are not typically thought of as being easily reversible, Calakos said.
Intriguingly, by taking normal laboratory mice and giving them a drug that boosted mGluR5 activity, Calakos’s team could instantaneously recreate the same excessive grooming and anxiety behaviors they saw in the Sapap3-lacking mice.
The researchers found that without a functioning Sapap3 protein, the mGluR5 receptor is always on. That, in turn, makes the brain regions involved in compulsion overactive. In particular, a group of neurons that give the “green light” for an action, like face-washing, is working overtime. (These same neurons can promote a habit, such as eating sweets, according to a study published by Calakos’s team earlier this year.)
Calakos said that mGluR5 should be considered for the treatment of compulsive behaviors. “But which people and which compulsive behaviors? We don’t know yet,” she added.
Other lines of research have explored targeting mGluR5 with drugs to move its activity up or down in the brain. For example, mGluR5-blockers are being considered for the treatment of Parkinson’s disease. But because mGluR5 inhibitors have not always panned out in clinical trials, it may make sense to target different parts of the mGluR5 pathway or identify specific patient subsets, Calakos said. New non-invasive imaging technologies now make it possible to measure mGluR5 activity in humans.
Learn more: Study Points to Fast-Acting Drug for OCD
The Latest on: Obsessive-compulsive disorder
via Google News
The Latest on: Obsessive-compulsive disorder
- Less healthy than Gen Xers, millennials see rise in depression, substance abuseon December 1, 2019 at 3:08 am
“I think you just get to the point where you’re like, ‘I don’t want to live like this anymore,’” said Old Saybrook resident Collin Schuster, 25, who has been diagnosed with obsessive-compulsive ...
- Lili Reinhart clarifies that she does have OCD, but what are the symptoms of the condition?on November 30, 2019 at 12:05 pm
Many of us would likely admit to making a flippant quip about being ‘a little bit OCD’. In fact the shortened term for Obsessive Compulsive Disorder is bandied about so regularly in everyday chat that ...
- Shining lighton November 28, 2019 at 4:49 pm
They offer a better understanding of illnesses and disorders such as bipolar disorder, obsessive–compulsive disorder, depression, schizophrenia, Down syndrome, as well as autism. The films include ...
- What is obsessive-compulsive personality disorder?on November 28, 2019 at 10:09 am
Obsessive-compulsive personality disorder (OCPD) is a medical condition that causes a person to experience an overwhelming need for order, perfectionism, and mental and interpersonal control. People ...
- What It’s Like to Live with Both a Mental and Physical Illness at the Same Timeon November 26, 2019 at 6:13 pm
I am one of those lucky people who live with both a chronic illness and mental illness. I have ulcerative colitis, a form of inflammatory bowel disease which led to the removal of my large intestine, ...
- Scrupulosity OCD Treatment Shouldn't Be a Hard Sellon November 26, 2019 at 12:54 pm
Years ago, I worked with a woman named Sandra who suffered from Scrupulosity, a religious and morally focused form of Obsessive Compulsive Disorder. She was a very devout woman in her mid 20s and on ...
- CBT improves long-term outcomes for anxiety-related disorderson November 26, 2019 at 8:43 am
“The results of this meta-analysis suggest that, on average, CBT was associated with moderate symptom reductions in anxiety disorders, PTSD and [obsessive-compulsive disorder] until 12 months after ...
- Know How Obsessive-Compulsive Disorder Treatment Market to Expand and Top Players Aims to Take Advantage of This Situationon November 26, 2019 at 8:42 am
Approved therapies dominate the obsessive-compulsive disorder drugs market. However, the heterogeneous nature of both OCD disorder and patients’ response to treatment has increased the use of ...
- Cohort study reveals age-specific risks for childhood and adolescent mental disorderson November 21, 2019 at 10:59 am
Among girls, anxiety disorder was the most common diagnosis (7.85%; 95% CI, 7.74-7.97), and ADHD was the most common in boys (5.9%; 95% CI, 5.76-6.03). The risks for schizophrenia, ...
- Khloe Kardashian sees a therapist over her obsessive compulsive disorder and anxietyon November 19, 2019 at 1:37 am
Kris then encouraged Khloe to see an exposure therapist who specialises in anxiety and obsessive compulsive disorder, and although she was sceptical at first, she agreed to do one session with her, ...
via Bing News